Phillips-Medisize Corporation announces the completion of the 33,000 sq. ft. expansion to their New Richmond, Wisconsin medical facility.

November 4, 2015 (Hudson, Wisconsin) Phillips-Medisize Corporation announced today, completion of the 33,000 sq. ft. expansion to their New Richmond, Wisconsin medical facility. The New Richmond facility is focused on the manufacturing and assembly of diagnostic and surgical products and this expansion includes additional controlled manufacturing and clean room space. This expansion is the direct result of the company’s continued year-over-year, double-digit growth and increased demand from customers such as Antares Pharma, Inc. and Exact Sciences.

With the significant, sustained growth that Phillips-Medisize has experienced over the past four years, the company is also actively recruiting engineers, mold techs and other medical device manufacturing and operations professionals to support this growth. The company plans to add a significant number of new technical positions within operations, quality and engineering, along with several production employees at the New Richmond site in 2015 and early 2016.

In commenting on this facility expansion, Matt Jennings, Chairman and CEO of Phillips-Medisize Corporation said, “We are very excited about the growth that we continue to experience at Phillips-Medisize. Obviously this growth is a function of the trust and confidence our customers have in our ability to execute for them. This expansion is simply the manifestation of that trust. Having the right facilities at the right time and place is one of the company’s strategic pillars, as well as, having the right and most creative employees on staff. We will continue to invest in this business based on our strategic plan that we put into effect more than four years ago.”

About Phillips-Medisize Corporation
Phillips-Medisize is a leading global outsource provider of design and manufacturing services to the drug delivery, consumable diagnostics and medical device, and specialty commercial markets. The company has annual sales of over $600 million with 80% of the total revenue coming from drug delivery, medical device, primary pharmaceutical packaging and diagnostic products such as: disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components.

Phillips-Medisize Corporation features a list of blue chip medical device, pharmaceutical and commercial customers. The company partners with its customers to provide design and development services which accelerate speed to market of innovative products and then works with its customers to deploy advanced automated assembly and quality control technologies which reduce manufacturing cost while improving quality. The company’s core advantage is the knowledge of its people to integrate design, molding, and automation to drive low cost and high quality manufacturing solutions.

Phillips-Medisize Corporation is headquartered in Hudson, WI, and employs over 3,400 people in 14 locations throughout the United States, Europe, Mexico and China. The company also has design centers in Wisconsin, California, and The Netherlands.